Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and immunogenicity of sequential vaccination with Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Live Attenuated Poliomyelitis Vaccine (Oral polio vaccine (live attenuated))
• Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) (Sabin inactivated poliovirus vaccine (Vero cell))

Snippet

Sponsor: Beijing Minhai Biotechnology Co., Ltd | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED